Low event rate for stress-only perfusion imaging in patients evaluated for chest pain

被引:86
作者
Gibson, PB
Demus, D
Noto, R
Hudson, W
Johnson, LL
机构
[1] Rhode Isl Hosp, Providence, RI 02903 USA
[2] Brown Univ, Providence, RI 02912 USA
关键词
D O I
10.1016/S0735-1097(02)01720-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES We sought to demonstrate the safety of stress-only perfusion imaging among patients with low to medium probability of coronary disease being evaluated for chest pain. BACKGROUND The need for performing rest in addition to stress perfusion imaging to confirm normalcy is due largely to defects created on the stress images by attenuation artifacts. A low cardiac event rate among patients undergoing stress-only imaging with attenuation correction (AC) would validate the safety of stress-only imaging. METHODS Patients with low to medium pretest probability for coronary artery disease (CAD) referred for chest pain evaluation from July 1, 1997 to July 1, 1999, were scheduled for a two-day stress/rest tomographic (single photon emission computerized tomography, or SPECT) perfusion imaging study with Tc-99m sestamibi. Patients were imaged on a variable angle camera with AC using Gd-153 scanning line sources (Vantage ADAC, Milpitas, California). If the stress scan was normal without AC or corrected with AC, the patient did not return for rest scan and was followed. RESULTS Seven hundred twenty-nine patients underwent stress-only imaging, and follow-up was obtained on 652 (89%) of those patients. There were 224 males and 429 females with mean age of 52 13 years. Mean follow-up was 22.3 +/- 6.4 months. The mean pretest probability was 37 +/- 24%. The non-AC images showed breast and/or diaphragmatic attenuation artifacts severe enough to have required the patient to return for rest imaging in 37% of patients, and all corrected completely with AC. During follow-up, there were two noncardiac deaths and no cardiac deaths. There was one myocardial infarction; three patients with progressive unstable angina underwent diagnostic coronary angiography showing significant CAD. The overall cardiac event rate was 0.6%. CONCLUSIONS These results support stress-only imaging in patients with low to medium probability for CAD as a safe, time- and cost-efficient imaging modality. (J Am Coll Cardiol 2002;39: 999-1004) (C) 2002 by the American College of Cardiology Foundation.
引用
收藏
页码:999 / 1004
页数:6
相关论文
共 23 条
[1]   SEPARATE ACQUISITION REST THALLIUM-201/STRESS TC-99M SESTAMIBI DUAL-ISOTOPE MYOCARDIAL PERFUSION SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY - A CLINICAL VALIDATION-STUDY [J].
BERMAN, DS ;
KIAT, H ;
FRIEDMAN, JD ;
WANG, FP ;
VANTRAIN, K ;
MATZER, L ;
MADDAHI, J ;
GERMANO, G .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (05) :1455-1464
[2]   INCREMENTAL VALUE OF PROGNOSTIC TESTING IN PATIENTS WITH KNOWN OR SUSPECTED ISCHEMIC-HEART-DISEASE - A BASIS FOR OPTIMAL UTILIZATION OF EXERCISE TC-99M SESTAMIBI MYOCARDIAL PERFUSION SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY [J].
BERMAN, DS ;
HACHAMOVITCH, R ;
KIAT, H ;
COHEN, I ;
CABICO, JA ;
WANG, FP ;
FRIEDMAN, JD ;
GERMANO, G ;
VANTRAIN, K ;
DIAMOND, GA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (03) :639-647
[3]  
BROWN KA, 1994, J NUCL MED, V35, P554
[4]  
Case JA, 2001, J NUCL MED, V42, p51P
[5]   Clinical review of attenuation-corrected cardiac SPECT [J].
Corbett, JR ;
Ficaro, EP .
JOURNAL OF NUCLEAR CARDIOLOGY, 1999, 6 (01) :54-68
[6]  
DEPUEY EG, 1989, J NUCL MED, V30, P441
[7]   THE INCONSISTENT PATTERN OF THALLIUM DEFECTS - A CLUE TO THE FALSE POSITIVE PERFUSION SCINTIGRAM [J].
DUNN, RF ;
WOLFF, L ;
WAGNER, S ;
BOTVINICK, EH .
AMERICAN JOURNAL OF CARDIOLOGY, 1981, 48 (02) :224-232
[8]   Simultaneous transmission emission myocardial perfusion tomography diagnostic accuracy of attenuatian-corrected Tc-99m-sestamibi single-photon emission computed tomography [J].
Ficaro, EP ;
Fessler, JA ;
Shreve, PD ;
Kritzman, JN ;
Rose, PA ;
Corbett, JR .
CIRCULATION, 1996, 93 (03) :463-473
[9]  
GALT JR, 1992, J NUCL MED, V33, P2232
[10]  
Galt JR, 1999, J NUCL MED, V40, p286P